Torsades de pointes after prolonged intravenous amiodarone therapy for atrial fibrillation

Amiodarone can induce TdP; therefore, it should be avoided as a first choice for therapy in patients without heart disease. Careful QT interval monitoring, especially during intravenous use, can prevent development of this life‐threatening arrhythmia.

Detalles Bibliográficos
Autores principales: Nordkin, Irina, Levinas, Tatyana, Rosenfeld, Inna, Halabi, Majdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813084/
https://www.ncbi.nlm.nih.gov/pubmed/33489188
http://dx.doi.org/10.1002/ccr3.3539
Descripción
Sumario:Amiodarone can induce TdP; therefore, it should be avoided as a first choice for therapy in patients without heart disease. Careful QT interval monitoring, especially during intravenous use, can prevent development of this life‐threatening arrhythmia.

Ejemplares similares